ArticleFrontiers in oncology2022

Efficacy and Adverse Events of Apatinib Salvage Treatment for Refractory Diffuse Malignant Peritoneal Mesothelioma: A Pilot Study.

Zhi-Ran Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.